blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4146109

EP4146109 - DUAL WAVELENGTH LASER ABLATION SYSTEMS FOR MRI-GUIDED ABLATION PROCEDURES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  10.02.2023
Database last updated on 05.10.2024
FormerThe international publication has been made
Status updated on  12.11.2021
Formerunknown
Status updated on  29.05.2021
Most recent event   Tooltip19.04.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Medtronic Navigation, Inc.
826 Coal Creek Circle
Louisville CO 80027 / US
[2023/11]
Inventor(s)01 / DROWN, Christine
Louisville, Colorado 80027 / US
02 / VINCELETTE, Rebecca
Louisville, Colorado 80027 / US
03 / SHAH, Roopali
Louisville, Colorado 80027 / US
04 / BARNEY, Nicole
Louisville, Colorado 80027 / US
05 / EWING, Benjamin
Louisville, Colorado 80027 / US
 [2023/11]
Representative(s)Zimmermann & Partner Patentanwälte mbB
Postfach 330 920
80069 München / DE
[2023/11]
Application number, filing date21726814.330.04.2021
[2023/11]
WO2021US30292
Priority number, dateUS202063019810P04.05.2020         Original published format: US 202063019810 P
[2023/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021225906
Date:11.11.2021
Language:EN
[2021/45]
Type: A1 Application with search report 
No.:EP4146109
Date:15.03.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 11.11.2021 takes the place of the publication of the European patent application.
[2023/11]
Search report(s)International search report - published on:EP11.11.2021
ClassificationIPC:A61B18/22
[2023/11]
CPC:
A61B18/22 (EP,US); A61B18/20 (US); A61B2017/00128 (EP);
A61B2017/0023 (US); A61B2018/00005 (US); A61B2018/00017 (EP);
A61B2018/00023 (EP); A61B2018/00446 (EP); A61B2018/00577 (EP,US);
A61B2018/00642 (EP,US); A61B2018/00672 (EP); A61B2018/00678 (EP);
A61B2018/00702 (EP,US); A61B2018/00714 (EP); A61B2018/00744 (EP);
A61B2018/00761 (EP); A61B2018/00791 (EP,US); A61B2018/00809 (EP);
A61B2018/207 (EP,US); A61B2018/2075 (EP); A61B2018/2261 (EP);
A61B2034/2051 (US); A61B34/25 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/11]
TitleGerman:LASERABLATIONSSYSTEME MIT ZWEI WELLENLÄNGEN FÜR MRT-GEFÜHRTE ABLATIONSVERFAHREN[2023/11]
English:DUAL WAVELENGTH LASER ABLATION SYSTEMS FOR MRI-GUIDED ABLATION PROCEDURES[2023/11]
French:SYSTÈMES D'ABLATION LASER À DOUBLE LONGUEUR D'ONDE POUR DES PROCÉDURES D'ABLATION GUIDÉES PAR IRM[2023/11]
Entry into regional phase29.11.2022National basic fee paid 
29.11.2022Designation fee(s) paid 
29.11.2022Examination fee paid 
Examination procedure29.11.2022Examination requested  [2023/11]
29.11.2022Date on which the examining division has become responsible
16.05.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
20.04.2023Renewal fee patent year 03
18.04.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]EP1958584  (SADE SHARON [IL]) [X] 1,6,8-10,13 * paragraphs [0016] , [0012] , [0025] , [0035] - [0036] - [0040] , [0045] , [0050]; figures 1B, 3 *;
 [XI]WO2008153999  (CYNOSURE INC [US], et al) [X] 1,6-11 * page 27, line 6 - page 37, line 20; figures 1,30,31 *[I] 13;
 [X]US2009248004  (ALTSHULER GREGORY B [US], et al) [X] 1,2,5,6,8-11,13 * paragraphs [0071] , [0171] , [0177] - [0181] - [0197] , [0200] , [0226] , [0237] , [0253] , [0287] , [0383]; figure 3D *;
 [X]US2012232534  (RINK JOHN L [US], et al) [X] 1,5,8-10 * paragraphs [0013] , [0036] , [0039] , [0053] , [0081]; claims 12,13 *;
 [X]US2014147802  (NALDONI MORENO [IT]) [X] 1,6-10 * paragraphs [0018] - [0024] - [0041] , [0053]; figure 1; claims 12-17 *;
 [X]US2018140866  (DALY JOHN G [US], et al) [X] 1,6,8-10 * paragraphs [0041] - [0044] - [0081] , [0098] , [0109]; figures 1,4,12 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.